Exelixis, Inc.

Exelixis, Inc. is a perfect momentum stock. Exelixis, Inc. has good growth characteristics. Exelixis, Inc. is not very popular among insiders. Exelixis, Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization,...
EXEL Fundamental Data by TradingView

News

Texas Permanent School Fund Corp Purchases 14,302 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Texas Permanent School Fund Corp Purchases 14,302 Shares of Exelixis, Inc. (NASDAQ:EXEL)

Ticker Report Texas Permanent School Fund Corp grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 5.4% during the 2nd quarter, Holdings Channel.com reports. The firm owned 279,654 shares...\n more…

Arizona State Retirement System Sells 2,639 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Arizona State Retirement System Sells 2,639 Shares of Exelixis, Inc. (NASDAQ:EXEL)

Zolmax Arizona State Retirement System cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 3.4% in the second quarter, according to the company in its most recent filing with the...\n more…

Investors Purchase High Volume of Call Options on Exelixis (NASDAQ:EXEL)
Investors Purchase High Volume of Call Options on Exelixis (NASDAQ:EXEL)

Zolmax Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors acquired 7,116 call options on the company. This represents an...\n more…

Savant Capital LLC Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL)
Savant Capital LLC Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL)

Ticker Report Savant Capital LLC reduced its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 13.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund...\n more…

Candriam S.C.A. Has $15.90 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)
Candriam S.C.A. Has $15.90 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)

Zolmax Candriam S.C.A. lowered its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 6.3% in the second quarter, according to the company in its most recent disclosure with the Securities and...\n more…

Exelixis (EXEL) Down 3.4% Since Last Earnings Report: Can It Rebound?
Exelixis (EXEL) Down 3.4% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research A month has gone by since the last earnings report for Exelixis (EXEL). Shares have lost about 3.4% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up...\n more…